Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01644643 · ClinicalTrials.gov registry record · Phase 3

Ceftazidime-Avibactam for the Treatment of Infections Due to Ceftazidime Resistant Pathogens

A Phase 3 study of Complicated Urinary Tract Infection and Complicated Intra-abdominal Infection, sponsored by Pfizer.

Completed
Registry status
Phase 3
Development phase
345
Enrollment target
20
Study locations

NCT01644643 is a Phase 3 study of Complicated Urinary Tract Infection and Complicated Intra-abdominal Infection that has completed, run by Pfizer. The registered enrollment target is 345 participants. The trial reports 20 study locations across 3 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01644643, a Phase 3 study of Complicated Urinary Tract Infection and Complicated Intra-abdominal Infection, has completed, sponsored by Pfizer.

COMPLETED
Registry status
Phase 3
Development phase
345 participants
Enrollment target
20
Study locations

Study Summary

To Evaluate the Effects of Ceftazidime-Avibactam and Best Available Therapy in patients with complicated urinary tract infections and complicated intra-abdominal infections.

Conditions Studied

Complicated Urinary Tract Infection Complicated Intra-abdominal Infection

Interventions

  • DRUG Metronidazole
  • DRUG Ceftazidime - Avibactam ( CAZ-AVI)
  • DRUG Best Available Therapy

Study Locations (20)

Other

  • Research Site - El Talar
  • Research Site - La Plata
  • Research Site - Pazardzhik
  • Research Site - Pleven
  • Research Site - Rousse
  • Research Site - Sofia
  • Research Site - Varna
  • Research Site - Veliko Tarnovo
  • Research Site - Slavonski Brod
  • Research Site - Zagreb
  • Research Site - Prague
  • Research Site - Tours
  • Research Site - Nazareth
  • Research Site - Petah Tikva
  • Research Site - Ramat Gan
  • Research Site - Tel Aviv
  • Research Site - Guadalajara
  • Research Site - Mexico City

Louisiana

  • Research Site - Shreveport

Ohio

  • Research Site - Lima

Trial Details

FieldValue
Enrollment Target 345 participants
Start Date 2013-01
Est. Completion 2014-09
Phase Phase 3

Sponsor

Pfizer

1,845 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT01644643

The ClinicalTrials.gov registry entry for NCT01644643 describes a study currently listed as completed, categorized as Phase 3. The registered enrollment target is 345 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Pfizer, which has 1,845 total studies on file at ClinicalTrials.gov.

The record links to 2 conditions, with Complicated Urinary Tract Infection appearing as the primary indexed condition, and to 3 interventions - of which Metronidazole is the first listed.

NCT01644643 reports 20 study locations spanning 3 distinct geographic areas - top geographies include Other, Louisiana, Ohio.

Frequently Asked Questions

What is clinical trial NCT01644643 about?

NCT01644643 is a clinical study titled "Ceftazidime-Avibactam for the Treatment of Infections Due to Ceftazidime Resistant Pathogens". To Evaluate the Effects of Ceftazidime-Avibactam and Best Available Therapy in patients with complicated urinary tract infections and complicated intra-abdominal infections.

What is the current status of trial NCT01644643?

This trial is currently completed. It is a Phase 3 study. The enrollment target is 345 participants. The study started on 2013-01. Estimated completion is 2014-09.

What conditions does trial NCT01644643 study?

This clinical trial studies the following conditions: Complicated Urinary Tract Infection, Complicated Intra-abdominal Infection.

What interventions are being tested in trial NCT01644643?

The interventions under investigation include: Metronidazole (DRUG), Ceftazidime - Avibactam ( CAZ-AVI) (DRUG), Best Available Therapy (DRUG).

Who is sponsoring clinical trial NCT01644643?

This trial is sponsored by Pfizer, which has 1,845 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT01644643 being conducted?

This trial has 20 study locations across Louisiana, Ohio. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Complicated Urinary Tract Infection

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Complicated Urinary Tract Infection

All registered trials for this condition

Complicated Intra-abdominal Infection

All registered trials for this condition

Louisiana

All trials with a study site in Louisiana

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.